Inactive Instrument
Eidos Therapeutics, Inc. Stock
Stocks
EIDX
US28249H1041
Biotechnology & Medical Research
| 1 day | -4.85% |
| Manager | Title | Age | Since |
|---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 47 | 2016-02-29 |
Jonathan Fox
PSD | President | 69 | 2016-09-30 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 69 | 2016-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan A. Barr
BRD | Director/Board Member | - | 2021-01-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/26/21 | Tender | Director | 113,325 | 0.2916% | ||
| 1/26/21 | Issuer sale | Director | 25,973 | 0.0668% | ||
| 1/26/21 | Don | Chief Technology Officer | 366,525 | 0.9431% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.85% | -4.63% | - | - | 4.75B | |
| +8.49% | +23.38% | +65.44% | +104.90% | 62.92B | |
| +1.25% | +2.22% | +31.00% | +70.51% | 54.32B | |
| +2.72% | +0.88% | -15.84% | -12.03% | 22.91B | |
| -1.09% | +29.18% | +17.83% | +496.18% | 28.73B | |
| +10.83% | +21.32% | +45.03% | +2.02% | 21.65B | |
| +6.50% | +8.41% | +45.17% | -21.02% | 17.76B | |
| -3.88% | +20.98% | +201.07% | +350.94% | 16.47B | |
| +6.20% | +12.16% | +28.51% | +629.05% | 15.48B | |
| +3.58% | -3.39% | +43.38% | +166.75% | 13.12B | |
| Average | +2.98% | +7.42% | +51.29% | +198.59% | 28.15B | |
| Weighted average by Cap. | +4.03% | +9.95% | +47.56% | +164.93% |
Employees
-
